Claritev Total Liabilities 2019-2025 | CTEV

Claritev total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Claritev Annual Total Liabilities
(Millions of US $)
2024 $5,067
2023 $5,256
2022 $5,581
2021 $5,876
2020 $5,726
2019 $6,375
2018 $0
Claritev Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $5,070
2024-12-31 $5,067
2024-09-30 $5,112
2024-06-30 $5,139
2024-03-31 $5,196
2023-12-31 $5,256
2023-09-30 $5,308
2023-06-30 $5,368
2023-03-31 $5,427
2022-12-31 $5,581
2022-09-30 $5,755
2022-06-30 $5,807
2022-03-31 $5,884
2021-12-31 $5,876
2021-09-30 $5,923
2021-06-30 $6,004
2021-03-31 $5,979
2020-12-31 $5,726
2020-09-30 $49
2020-06-30 $40
2020-03-31 $39
2019-12-31
2018-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.013B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.259B 57.58
Doximity (DOCS) United States $11.613B 51.53
Hims & Hers Health (HIMS) United States $11.187B 92.56
Tempus AI (TEM) United States $10.529B 0.00
IRhythm Technologies (IRTC) United States $5.158B 0.00
Hinge Health (HNGE) United States $4.347B 0.00
Privia Health (PRVA) United States $2.493B 184.64
Inspire Medical Systems (INSP) United States $2.355B 34.62
Phreesia (PHR) United States $1.614B 0.00
Enovis (ENOV) United States $1.607B 8.49
10x Genomics (TXG) United States $1.516B 0.00
Omnicell (OMCL) United States $1.416B 27.28
Schrodinger (SDGR) United States $1.367B 0.00
Azenta (AZTA) United States $1.283B 55.96
Clover Health Investments (CLOV) United States $1.257B 0.00
Evolent Health (EVH) United States $1.082B 0.00
Fulgent Genetics (FLGT) United States $0.631B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Standard BioTools (LAB) United States $0.486B 0.00
Zepp Health (ZEPP) Netherlands $0.461B 0.00
Talkspace (TALK) United States $0.412B 123.00
Carlsmed (CARL) $0.346B 0.00
Butterfly Network (BFLY) United States $0.342B 0.00
TruBridge (TBRG) United States $0.288B 50.50
Nyxoah SA (NYXH) Belgium $0.239B 0.00
Outset Medical (OM) United States $0.221B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
CapsoVision (CV) United States $0.190B 0.00
Health Catalyst (HCAT) United States $0.188B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.136B 0.00
American Well (AMWL) United States $0.112B 0.00
CareCloud (CCLD) United States $0.108B 4.92
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.088B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.075B 0.00
Pulmonx (LUNG) United States $0.063B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
HeartBeam (BEAT) United States $0.032B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
MSP Recovery (MSPR) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00